TMCnet News

Sapiens Reports Q4 2016 Financial Results
[February 28, 2017]

Sapiens Reports Q4 2016 Financial Results


HOLON, Israel, Feb. 28, 2017 /PRNewswire/ --  Sapiens International Corporation, (NASDAQ: SPNS; TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ: FORTY; TASE: FORTY), today announced its financial results for the fourth quarter which ended on December 31, 2016.

Sapiens International Corporation Logo

Fourth Quarter Highlights:

  • GAAP and non-GAAP revenue of $57.1 million, up 17.3% compared to $48.7 million in the fourth quarter of 2015.
  • GAAP operating profit totaled $5.6 million (9.8% operating margin), compared to $6.8 million (14.0% operating margin) in the fourth quarter of 2015.
  • Non-GAAP operating profit totaled $7.5 million (13.1% operating margin), compared to $7.4 million (15.1% operating margin) in the fourth quarter of 2015.
  • GAAP net income attributable to Sapiens' shareholders totaled $3.8 million or $0.08 per diluted share, compared to $5.9 million or $0.12 per diluted share in the fourth quarter last year.
  • Non-GAAP net income attributable to Sapiens' shareholders totaled $6.0 million or $0.12 per diluted share, compared to $6.3 million or $0.13 per diluted share in the fourth quarter last year.
  • Cash, cash equivalents and securities investments as of December 31, 2016 were $96.4 million and Sapiens has no debt.

Full Year Financial Highlights:

  • GAAP revenue of $216.2 million, up 16.5% compared to $185.6 million in 2015.
  • Non-GAAP revenue increased by 20.6% to $216.2 million compared to $179.3 million in 2015.
  • GAAP operating profit totaled $24.8 million (11.5% operating margin), compared to $24.4 million (13.1% operating margin) in 2015.
  • Non-GAAP operating profit was $29.6 million (13.7% operating margin), compared to $26.5 million (14.8% operating margin) in 2015.
  • GAAP net income attributable to Sapiens' shareholders totaled $19.3 million or $0.40 per diluted share, compared to $20.0 million or $0.41 per diluted share in 2015.  
  • Non-GAAP net income attributable to Sapiens' shareholders reached $24.2 million, or $0.49 per diluted share compared to $22.1 million, or $0.45 per diluted share in the year ago period.

"Sapiens delivered another solid quarter with double-digit revenue growth and strong performance across all of our offerings and territories, driven by increased demand for our products and services," said Roni Al-Dor, president and CEO of Sapiens. "I am pleased with our continued geographic expansion and our organic growth."

"On the M&A front, we are very excited about our recently announced acquisition of StoneRiver, Inc. which significantly expands Sapiens' presence and scale in the North American insurance market and accelerates our entry into the U.S. property and casualty (P&C) market," continued Al-Dor. "Overall, we believe this acquisition is completely aligned with our M&A growth strategy to increase our customer base, expand geographically and add complementary solutions to our product portfolio. We are confident that with StoneRiver, we will strengthen our position as a leading and innovative global software solutions provider, offering end-to-end solutions to the global insurance industry."

Added Al-Dor, "Beyond the acquisition, Sapiens had a very active quarter. Generali Nederland selected Sapiens for its life portfolios, and LB Group chose our Sapiens IDIT P&C suite as its new policy administration solution. Also, we launched a consumer and agent portal for L&A and P&C insurers. In addition, in terms of geographies, we expanded our presence in the Nordic region with a new head office in Copenhagen, and we opened a new local support center in Istanbul, Turkey."

Mr. Al-Dor concluded, "We are providing our guidance for 2017 full year revenues of $270 to $280 million, or annual growth of 25%-30%, and we expect full-year 2017 non-GAAP operating margins of approximately 13%. This guidance reflects the impact of the StoneRiver acquisition."

Quarterly Results Conference Call

Management will host a conference call and webcast on February 28 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call one of the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): +1-888-668-9141; International: +972-3-918-0609; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at:
http://www.sapiens.com/investors/presentations-and-webcast/

If you are unable to join live, a replay of the call will be accessible until March 10, 2017, as follows:
North America: +1-888-326-9310; International: +972-3-925-5904

A recorded version of the webcast will also be available for three months via the Sapiens website, at the same web location listed above.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: Non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Management of the Company does not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures. In order to compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

In addition, the Company adjusted revenues and expenses, recorded under U.S. GAAP, of the pre-acquisition date in respect of acquired business from its ultimate parent company. As this transaction is between companies under common control, under U.S. GAAP, it was accounted for under the pooling of interest method. For non-GAAP measurement purposes, the Company excludes the pre-acquisition date revenues and expenses.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for stock-based compensation expense, depreciation and amortization, capitalized internal-use software development costs, amortization of internal-use software development costs interest expense, compensation expenses related to acquisition, pre-acquisition revenues and expenses accounted under pooling of interest method, provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business. The Company uses Adjusted EBITDA as a measurement of its operating performance because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflect an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures provide a more complete understanding of factors and trends affecting its business.

About Sapiens

Sapiens International Corporation (NASDAQ and TASE: SPNS) is a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. We offer core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, and retirement markets, as well as business decision management software. We have a track record of over 30 years in delivering superior software solutions to more than 200 financial services organizations. The Sapiens team of approximately 1,900 professionals operates through our fully-owned subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific. For more information: www.sapiens.com.

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will", "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2016, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.        

 





SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)





  Three months ended


  Year ended




December 31,


 December 31,




2016


2015


2016


2015*




 (unaudited)


 (unaudited)


 (unaudited)


 (unaudited)











 Revenue


57,113


48,674


216,190


185,636

 Cost of revenue


34,648


28,633


130,402


111,192











 Gross profit


22,465


20,041


85,788


74,444











 Operating Expenses:










 Research and development, net


5,087


2,747


16,488


10,235


 Selling, marketing, general and administrative


11,787


10,498


44,460


39,859

 Total operating expenses


16,874


13,245


60,948


50,094











 Operating income


5,591


6,796


24,840


24,350











 Financial expense (income), net


98


(402)


(533)


(163)

 Taxes expenses, net


1,383


1,192


5,772


4,213





















 Net income


4,110


6,006


19,601


20,300











 Attributable to non-controlling interest


299


134


265


284











 Net income attributable to Sapiens' shareholders


3,811


5,872


19,336


20,016





















 Basic earnings per share**


0.08


0.12


0.40


0.42











 Diluted earnings per share**


0.08


0.12


0.40


0.41











Weighted average number of shares outstanding used to
compute basic earnings per share (in thousands)


49,021


48,758


48,947


48,121










Weighted average number of shares outstanding used to
compute diluted earnings per share (in thousands)


49,935


49,536


49,780


49,327


* Including consolidation of Insseco, commencing December 31, 2014.

** Net income used for earning per share was adjusted to reflect the effect of redeemable non-controlling interest.



 

 

Summary of non-GAAP Financial Information

U.S. dollars in thousands (except per share amounts)



Three months ended


  Year ended


December 31,


 December 31,


2016


2015


2016


2015


(unaudited)


(unaudited)


(unaudited)


(unaudited)













Revenues

57,113

100%


48,674

100%


216,190

100%


179,263

100%













Gross Profit

23,850

41.8%


21,515

44.2%


91,767

42.4%


78,472

43.8%













Operating profit

7,493

13.1%


7,356

15.1%


29,615

13.7%


26,547

14.8%













Net income to shareholders

5,958

10.4%


6,332

13.0%


24,199

11.2%


22,105

12.3%













Adjusted EBITDA

8,298

14.5%


7,928

16.3%


32,450

15.0%


28,499

15.9%













Basic earnings per share

0.12



0.13



0.49



0.46


Diluted earnings per share

0.12



0.13



0.49



0.45


 

 


 

Non-GAAP revenues by geographic breakdown

U.S. dollars in thousands



Q4 2016


Q3 2016


Q2 2016


Q1 2016


Q4 2015











North America

21,107


19,706


17,601


16,041


16,767

Europe

28,292


28,675


26,124


28,421


26,439

APAC

7,714


8,099


9,305


5,105


5,468











Total

57,113


56,480


53,030


49,567


48,674

 

 

Adjusted EBITDA Calculation

U.S. dollars in thousands




Three months ended


Year ended



 December 31,


December 31,



2016


2015


2016


2015










GAAP operating profit


5,591


6,796


24,840


24,350










Non-GAAP adjustments:









Amortization of capitalized software


1,092


1,323


4,929


4,875

Amortization of other intangible assets


593


392


2,257


2,106

Capitalization of software development


(1,091)


(1,641)


(5,545)


(6,032)

Stock-based compensation


522


435


1,955


1,349

Compensation related to acquisition and
acquisition related costs


786


51


1,179


270

Adjustments of pre-acquisition revenues
and expenses accounted under pooling
of interest method


-


-


-


(371)










Non-GAAP operating profit


7,493


7,356


29,615


26,547










Depreciation


805


572


2,835


1,952










Adjusted EBITDA


8,298


7,928


32,450


28,499

 

 


SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)




  Three months ended


  Year ended



December 31,


December 31,



2016


2015


2016


2015*

GAAP revenue


57,113


48,674


216,190


185,636

Adjustments of pre-acquisition revenue accounted under
pooling of interest method


-


-


-


(6,373)

Non-GAAP revenue


57,113


48,674


216,190


179,263



















GAAP gross profit


22,465


20,041


85,788


74,444

Revenue adjustment


-


-


-


(6,373)

Amortization of capitalized software


1,092


1,323


4,929


4,875

Amortization of other intangible assets


293


151


1,050


794

Adjustments of pre-acquisition cost of revenue accounted under
pooling of interest method


-


-


-


4,732

Non-GAAP gross profit


23,850


21,515


91,767


78,472



















GAAP operating income


5,591


6,796


24,840


24,350

Gross profit adjustments


1,385


1,474


5,979


4,028

Capitalization of software development


(1,091)


(1,641)


(5,545)


(6,032)

Amortization of other intangible assets


300


241


1,207


1,312

Stock-based compensation


522


435


1,955


1,349

Compensation related to acquisition and acquisition related costs


786


51


1,179


270

Adjustments of pre-acquisition operating expenses accounted
under pooling of interest method


-


-


-


1,270

Non-GAAP operating income


7,493


7,356


29,615


26,547



















GAAP net income attributable to Sapiens' shareholders


3,811


5,872


19,336


20,016

Operating income adjustments


1,902


560


4,775


2,197

Adjustment to redeemable non-controlling interest


302


151


443


224

Adjustments of pre-acquisition financial and tax expenses
accounted under pooling of interest method


-


-


-


50

Other


(57)


(251)


(355)


(382)

Non-GAAP net income attributable to Sapiens' shareholders


5,958


6,332


24,199


22,105



















 Non-GAAP basic earnings per share 


0.12


0.13


0.49


0.46










 Non-GAAP diluted earnings per share


0.12


0.13


0.49


0.45



















Weighted average number of shares outstanding used to compute
basic earnings per share (in thousands)

49,021


48,758


48,947


48,121

Weighted average number of shares outstanding used to compute
diluted earnings per share (in thousands)

49,935


49,536


49,780


49,327


* Including consolidation of Insseco commencing the acquisition date, August 18, 2015.

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. Dollars in thousands





December 31,


December 31,




2016


2015




 (unaudited)


 (unaudited)







 ASSETS












 CURRENT ASSETS:






Cash and cash equivalents


60,908


54,351


Trade receivables, net


34,684


29,761


Other receivables and prepaid expenses


6,389


5,455


Marketable securities


18,220


8,776








 Total current assets


120,201


98,343







 LONG-TERM ASSETS:






Marketable securities


17,228


30,875


Property and equipment, net


9,807


5,675


Severance pay fund


4,041


5,551


Other intangible assets, net


28,354


27,540


Other long-term assets


4,623


4,252


Goodwill


73,597


70,035








 Total long-term assets


137,650


143,928







 TOTAL ASSETS


257,851


242,271







LIABILITIES AND EQUITY











 CURRENT LIABILITIES:






 Trade payables


6,562


4,721


 Accrued expenses and other liabilities


32,049


32,012


 Deferred revenue


9,137


10,268








Total current liabilities


47,748


47,001







 LONG-TERM LIABILITIES:






 Other long-term liabilities


9,864


6,414


 Accrued severance pay


4,940


6,662








 Total long-term liabilities


14,804


13,076













REDEEMABLE NON-CONTROLLING INTEREST


908


385







 EQUITY



194,391


181,809







 TOTAL LIABILITIES AND EQUITY


257,851


242,271

 

 


 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands



Year ended

December 31,


2016

2015


(unaudited)

(unaudited)

Cash flows from operating activities:



Net income

19,601

20,300

Reconciliation of net income to net cash provided by operating activities:



Depreciation and amortization

10,021

9,625

Amortization of premium and accrued interest on marketable securities

(516)

(453)

Stock-based compensation related to options issued to employees

1,955

1,349




Net changes in operating assets and liabilities, net of amount acquired:



Trade receivables

(5,435)

1,893

Deferred tax assets

1,664

2,169

Other operating assets

(3,309)

(1,229)

Trade payables

1,101

1,511

Other operating liabilities

2,223

4,134

Deferred revenues

(1,035)

1,300

Severance pay

(231)

(159)




Net cash provided by operating activities

26,039

40,440




Cash flows from investing activities:



Purchase of property and equipment

(4,664)

(2,815)

Purchase of marketable securities, net of interest received

(9,017)

(7,678)

Proceeds from sales of marketable securities

13,898

1,499

Payments for business acquisition, net of cash acquired

(4,382)

(2,934)

Capitalized software development costs

(5,545)

(6,032)

Restricted cash

1,393

(893)




Net cash used in investing activities

(8,317)

(18,853)




Cash flows from financing activities:



Proceeds from employee stock options exercised

890

1,568

Payment to shareholders in respect of acquisition

(1,440)

(8,482)

Distribution of dividend

(9,786)

(7,186)

Repayment of loan

(824)

-

Dividend to non-controlling interest

(73)

(77)




Net cash used in financing activities

(11,233)

(14,177)




Effect of exchange rate changes on cash and cash equivalents

68

(459)




Increase in cash and cash equivalents

6,557

6,951

Cash and cash equivalents at the beginning of period

54,351

47,400




Cash and cash equivalents at the end of period

60,908

54,351

 

Investors and Media Contact:
Yaffa Cohen-Ifrah
Chief Marketing Officer and Head of Corporate Communications
Sapiens International
US Mobile: +1-201-250-9414
Mobile: +972-54-9099039
Email: [email protected]

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sapiens-reports-q4-2016-financial-results-300414757.html

SOURCE Sapiens International Corporation


[ Back To TMCnet.com's Homepage ]